| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 02/23/2006 | WO2006020598A2 Amido compounds and their use as pharmaceuticals |
| 02/23/2006 | WO2006019151A1 Process for producing benzimidazole derivative |
| 02/23/2006 | WO2006018309A1 5-ht7 receptor antagonists |
| 02/23/2006 | WO2006018308A1 5-ht7 receptor antagonists |
| 02/23/2006 | WO2006018284A1 Compounds and compositions useful as cathepsin s inhibitors |
| 02/23/2006 | WO2006018260A1 Tetrahydrobenzazepines as antagonists and/or reverse agonists of the histamine h 3 receptor |
| 02/23/2006 | WO2005123688A3 3-aminoindazoles |
| 02/23/2006 | WO2005115145A3 Quinone substituted quinazoline and quinoline kinase inhibitors |
| 02/23/2006 | WO2005077903A3 Melanin concentrating hormone receptor ligands: substituted tetrahydroisoquinoline analogues |
| 02/23/2006 | WO2005003086A3 Sulfonic acid derivatives of polycyclic dyes used for analytical applications |
| 02/23/2006 | US20060041143 Method for synthesis of 5-(3-pyridylmethylene-)imidazolidine-2,4-dione |
| 02/23/2006 | US20060041142 demetallization to prepare of 2,4'-bipyridine, 4-methyl-2-(2'-pyridyl)pyridine, 2,3'-bipyridine, 6-chloro-2-(2'-thienyl)pyridine, or 2-(3'-thienyl)pyridine; synthetic intermediate for fungicides |
| 02/23/2006 | US20060041139 Antagonists for melanin concentrating hormone-1 receptors; antidepressants, anxiolytic agents; incontinence, obesity |
| 02/23/2006 | US20060041127 Method for the regioselective preparation of substituted benzo[g]quinoline-3-carbonitriles and benzo[g]quinazolines |
| 02/23/2006 | US20060041123 Antibacterial agents |
| 02/23/2006 | US20060041095 Intermediate products, methods for their preparation and use thereof |
| 02/23/2006 | US20060041034 Polyoxo derivatives of bis(pyrimidinylidene)-, bis(indanylidene)-, bis(dioxanylidene)- and bis(pyrazolylidene)- condensates of bisisoindolylidenes, e.g., 3,3'-Bis(1,3-dioxoindan-2-ylidene)-[1,1']biisoindolylidene and 3,3'-Bis(1,3-dimethyl-2,4,6-trioxotetrahydropyrimidin-5-ylidene)-[1,1']biisoindolylidene |
| 02/23/2006 | US20060040995 Method for preparing hydroxypicolinic scid derivatives |
| 02/23/2006 | US20060040989 N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein b secretion |
| 02/23/2006 | US20060040988 antiinflammatory, antipyretic and analgesic agents; side effects redution; N-(cyclohexylmethyl)-6-[4-(methylsulfonyl)phenyl]-4-(trifluoromethyl)-2-pyridinamine; osteoarthritis; rheumatoid arthritis |
| 02/23/2006 | US20060040986 Erythropoietin production accelerator |
| 02/23/2006 | US20060040984 Novel piperidine derivatives for use in the treatment of chemokine medicated disease states |
| 02/23/2006 | US20060040974 Decahydroisoquinolinyl- hydroxyethylamine derivatives; human immunodeficiency virus (HIV) protease |
| 02/23/2006 | US20060040973 Novel guanidine mimics as factor Xa inhibitors |
| 02/23/2006 | US20060040968 2-(Amino-substituted)-4-aryl pyrimidines and related compounds useful for treating inflammatory diseases |
| 02/23/2006 | US20060040967 6-Fluoroalkyl-4-(5-sulfonyl-2-pyridyl)-substituted, e.g., 4-(5-Methanesulfonyl-pyridin-2-yl)-6-trifluoromethyl-pyrimidin-2-yl]-methyl-(6-methyl-pyridin-2-ylmethyl)-amine; treating pain, fever and inflammation without the potential side effects of other COX inhibitors |
| 02/23/2006 | US20060040966 e.g. 2-(7-isoquinolinylamino)-N-(3-methyl-4-(1-methylethyl)phenyl)-3-pyridinecarboxamide; Vascular Endothelial Growth Factor antagonist; angiogenesis inhibitor; anticarcinogenic, antiinflammatory inhibitor; retinopathies, rheumatoid arthritis, asthma, atherosclerosis, endometriosis, neoplastic diseases |
| 02/23/2006 | US20060040956 Substituted alkylamine derivatives and methods of use |
| 02/23/2006 | US20060040950 Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists |
| 02/23/2006 | US20060040949 Treating antibiotic resistant bacterial infections; compounds based on quinoline rings; (3S)-2-(3-{[(Benzo[1,2,5]thiadiazol-5-ylmethyl)-amino]-methyl}-piperidin-1-yl)-(1RS)-(6-methoxy-quinolin-4-yl)-ethanol for example |
| 02/23/2006 | US20060040947 inflammation; N-(4-Phenylpyridin-2-yl)isoquinolin-5-amine; analgesis; antinociceptive agents |
| 02/23/2006 | US20060040941 7-Aminoimidazotriazones |
| 02/23/2006 | US20060040939 Benzamide inhibitors of the P2X, receptor |
| 02/23/2006 | US20060040937 N-aroyl cyclic amines as orexin receptor antagonists |
| 02/23/2006 | US20060040923 1,1-Diethyl-3-(2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-urea; respiratory syncytial virus; cost efficient replacement for Synagis (palivizumab) used for RSV; respiratory system disorders; asthna; viral diseases; myxoviruses; mumps; flaviviruses; dengue, West Nile, parainfluenza viruses |
| 02/23/2006 | US20060040918 Benzo d!azepine derivatives for the treatment of neurological disorders |
| 02/23/2006 | US20060040906 Piperazine urea derivatives as melanocortin-4 receptor agonists |
| 02/23/2006 | US20060040902 Compunds useful as pesticides |
| 02/23/2006 | US20060039962 Amphiphilic compounds and vesicles liposomes for organ-specified drug targeting |
| 02/23/2006 | DE10309929B4 Substituierte Benzoylureidopyridyl-piperidin- und -pyrrolidin-carbonsäurederivate, Verfahren zu deren Herstellung und deren Verwendung Benzoylureidopyridyl substituted-piperidine and -pyrrolidine carboxylic acid derivatives, processes for their preparation and their use |
| 02/23/2006 | DE102004039280A1 1,5-Diphenyl-pyrazole 1,5-diphenyl-pyrazoles |
| 02/23/2006 | CA2581327A1 Intracellular receptor modulator compounds and methods |
| 02/23/2006 | CA2577880A1 Compounds useful for inhibiting chk1 |
| 02/23/2006 | CA2577060A1 Substituted benzofused heterocycles |
| 02/23/2006 | CA2576993A1 Bisaryl-sulfonamides |
| 02/23/2006 | CA2576290A1 Method for the production of dihydropteridinones |
| 02/23/2006 | CA2575853A1 Isoindolone compounds and their use as metabotropic glutamate receptor potentiators |
| 02/23/2006 | CA2575826A1 Compounds and compositions useful as cathepsin s inhibitors |
| 02/23/2006 | CA2575785A1 5-ht7 receptor antagonists |
| 02/23/2006 | CA2575771A1 5-ht7 receptor antagonists |
| 02/23/2006 | CA2575561A1 Amido compounds and their use as pharmaceuticals |
| 02/23/2006 | CA2573764A1 Hydantoin derivatives for the treatment of inflammatory disorders |
| 02/23/2006 | CA2573730A1 1,2,3,4-tetrahydropyrazin-2-yl acetamides and their use as bradykinin antagonists for the treatment of inflammation related disorders |
| 02/22/2006 | EP1627880A1 Boronic ester and acid compounds, synthesis and uses |
| 02/22/2006 | EP1627875A1 Method for producing cyclic diamine derivative or salt thereof |
| 02/22/2006 | EP1627869A1 Amide derivative |
| 02/22/2006 | EP1626967A1 Substituted pyrazoles |
| 02/22/2006 | EP1626965A1 Pyrazinones as crf1 receptor antagonists for the treatment of cns disorders |
| 02/22/2006 | EP1626964A2 New benzimidazole derivatives |
| 02/22/2006 | EP1626960A1 Diarylmethylidene piperidine derivatives and their use as delta opioid receptor agonists |
| 02/22/2006 | EP1626958A1 (piperidinyloxy)phenyl, (piperidinyloxy)pyridinyl, (piperidinylsulfanyl)phenyl and (piperidinylsulfanyl)pyridinyl compounds as 5-ht 1f agonists |
| 02/22/2006 | EP1626725A2 Heterocyclic compounds for preventing and treating disorders associated with excessive bone loss |
| 02/22/2006 | EP1441735B1 N-substituted hydroxypyrimidinone carboxamide inhibitors of hiv integrase |
| 02/22/2006 | EP1406622B1 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 02/22/2006 | EP1385839B1 3-substituted quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 02/22/2006 | EP1237874B1 Selective neurokinin antagonists |
| 02/22/2006 | CN1738884A Electrochromic compounds |
| 02/22/2006 | CN1738817A Novel vitronectin receptor antagonist derivatives, method for preparing same, use thereof as medicines and pharmaceutical compositions containing same. |
| 02/22/2006 | CN1738814A Indolyl pyrazinone derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |
| 02/22/2006 | CN1738806A Oxo-azabicyclic compounds |
| 02/22/2006 | CN1738805A N- (1-benzyl-2-oxo-2- (1-piperazinyl) ethyl) -1-piperidincarboxamid-derivatives and related compounds use as CGRP-antagonists for treating a headache |
| 02/22/2006 | CN1738804A 吡唑化合物 Pyrazole compounds |
| 02/22/2006 | CN1738801A Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| 02/22/2006 | CN1738799A Methods for preparing phenylalkyne derivatives |
| 02/22/2006 | CN1738798A Indole derivatives as somatostatin agonists or antagonists |
| 02/22/2006 | CN1738618A Pharmaceutical compositions and their uses |
| 02/22/2006 | CN1738615A Diaminotriazoles useful as inhibitors of protein kinases |
| 02/22/2006 | CN1737064A Cationic diazo compound, compositions comprising at least one cationic diazo compound as a direct dye, a process for dyeing keratin fibers and device therefore |
| 02/22/2006 | CN1736985A Growth hormone secretagogues |
| 02/22/2006 | CN1243001C Method of manufacturing sertindole |
| 02/22/2006 | CN1242995C Novel compounds, their use and preparation |
| 02/22/2006 | CN1242993C Heterocycle derivatives and drugs |
| 02/22/2006 | CN1242992C Cyclic diamine compounds bearing six-membered cyclic groups |
| 02/22/2006 | CN1242989C Aryl phenycyclopropyl sulfide derivatives and their use as cell adhesion-ichibiting anti-inflammatory and immune-suppressive agents |
| 02/21/2006 | US7002022 treatment of neoplastic diseases that respond to inhibition of the vascular endothelial growth factor receptor tyrosine kinase activity; tumors, retinopathy, macular degeneration |
| 02/21/2006 | US7002015 3-Thia-4-arylquinolin-2-one derivatives as smooth muscle relaxants |
| 02/21/2006 | US7002013 Pt complexes as phosphorescent emitters in the fabrication of organic light emitting diodes |
| 02/21/2006 | US7001917 2-(4-(4-(4-Fluorophenyl)-3,5-imethyl-1H-pyrazol-1-yl)phenyl) ethyl (4-methylphenyl)sulfonylcarbamate ammonium salt, e.g., as an antagonist for Prostoglandin E receptor; analgesics; antipyretics; antiinflammatory agents |
| 02/21/2006 | US7001913 substituted naphthyridine aminopiperidines; bacterial infections |
| 02/21/2006 | US7001908 Arylpiperazines having activity at the serotonin 1A receptor |
| 02/21/2006 | US7001904 Guanidine derivatives quinazoline and quinoline for use in the treatment of autoimmune diseases |
| 02/21/2006 | US7001901 Tetrazolylpropionamides as inhibitors of Aβ protein production |
| 02/21/2006 | US7001898 Treating conditions involving increased vascular resistance and cardiac insufficiency. |
| 02/21/2006 | US7001887 Peptide derivatives |
| 02/21/2006 | CA2283399C Pyridazinones as inhibitors of cyclooxygenase-2 |
| 02/21/2006 | CA2250347C Piperazine and piperidine compounds with high affinity for dopamine-d2 and serotonin-5ht1a receptors |
| 02/21/2006 | CA2065986C 1-(pyrido[3,4-b]-1,4-oxazinyl-4-yl)-1h-indoles, intermediates and a process for their preparation, and their use as medicaments |
| 02/16/2006 | WO2006017639A2 Crystalline polymorph of pipindoxifene hydrochloride monohydrate |
| 02/16/2006 | WO2006017406A1 Cyanoamidine p2x7 antagonists for the treatment of pain |
| 02/16/2006 | WO2006017353A2 Treatment of viral infections |